Imad El-Kebbi
Endocrinology, Diabetes & Metabolism · Atlanta, GANPI 1295847366
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 87 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 10.8% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for endocrinology, diabetes & metabolism clinicians in GA, where the typical reported total is $2,873.
Across 87 payments — averaging $23.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi-aventis U.S. LLC$218
- Novo Nordisk$198
- Amgen$171
- Xeris Pharmaceuticals, Inc.$149
- Ascendis Pharma Endocrinology Inc$122
- Sequel Med Tech, LLC$95
- plus $1K from 25 others
What the payments were for
- Food & beverage$2,022100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi-aventis U.S. LLC | 7 | $218 |
| Novo Nordisk | 6 | $198 |
| Amgen | 8 | $171 |
| Xeris Pharmaceuticals, Inc. | 7 | $149 |
| Ascendis Pharma Endocrinology Inc | 5 | $122 |
| Sequel Med Tech, LLC | 5 | $95 |
| Rhythm Pharmaceuticals, Inc. | 3 | $82 |
| AbbVie | 5 | $78 |
| Lilly USA, LLC | 3 | $75 |
| Neurocrine Biosciences, Inc. | 3 | $75 |
| Recordati_rare_diseases_inc. | 3 | $74 |
| Madrigal Pharmaceuticals | 2 | $72 |
| Abbott | 3 | $63 |
| Boehringer Ingelheim | 3 | $60 |
| Radius Health, Inc. | 2 | $51 |
| Chiesi USA, Inc. | 2 | $49 |
| Tandem Diabetes Care, Inc. | 2 | $46 |
| AstraZeneca | 2 | $44 |
| Inspire Medical Systems, Inc. | 1 | $33 |
| Acella Pharmaceuticals, LLC | 2 | $30 |
| Amneal Pharmaceuticals LLC | 2 | $30 |
| Johnson & Johnson | 2 | $29 |
| Insulet Corporation | 1 | $28 |
| Kyowa Kirin, Inc. | 1 | $25 |
| Mannkind Corporation | 1 | $22 |
| Medtronic | 1 | $20 |
| Almatica Pharma LLC | 1 | $18 |
| Bayer | 1 | $16 |
| Cequr Corporation | 1 | $16 |
| Ionis Pharmaceuticals, Inc. | 1 | $15 |
| GSK | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Wegovy$125
How this compares
$2,022 in reported general payments places this provider in the 40th percentile of 222 endocrinology, diabetes & metabolism providers in Georgia.
See all endocrinology, diabetes & metabolism providers in Georgia →
Other endocrinology, diabetes & metabolism in Atlanta
- Bruce BodeAtlanta$1.5M
- David RobertsonAtlanta$1.4M
- Jonathan OwnbyAtlanta$291K
- Gulliermo UmpierrezAtlanta$63K
- Francisco PasquelAtlanta$40K
- Norman WelchAtlanta$25K
- Rachel DerrAtlanta$18K
- Kate WheelerAtlanta$17K
- John ZoraAtlanta$16K
- Ernest BeasleyAtlanta$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.